Pregled bibliografske jedinice broj: 809480
Potential of glycosylation research in graft versus host disease after allogeneic hematopoietic stem cell transplantation
Potential of glycosylation research in graft versus host disease after allogeneic hematopoietic stem cell transplantation // Biochimica et biophysica acta. G, General subjects, 1860 (2016), 8; 1615-1622 doi:10.1016/j.bbagen.2016.02.015 (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 809480 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Potential of glycosylation research in graft versus host disease after allogeneic hematopoietic stem cell transplantation
Autori
Prenc, Ema ; Pulanić, Dražen ; Pučić-Baković, Maja ; Pezer, Marija ; Desnica, Lana ; Vrhovac, Radovan ; Nemet, Damir ; Pavletić, Steven Živko
Izvornik
Biochimica et biophysica acta. G, General subjects (0304-4165) 1860
(2016), 8;
1615-1622
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
Glycan ; Glycosylation ; graft versus host disease ; hematopoietic stem cell transplantation
Sažetak
Background Glycans, complex oligosaccharides, are directly involved in almost every biological process, have a fundamental role in the immune system, and are probably involved in nearly every human disease. However, glycosylation has been greatly ignored in the area of allogeneic hematopoietic stem cell transplantation (alloHSCT) and graft versus host disease (GVHD). Both acute and chronic GVHD are multisystemic debilitating immunological disturbances arising after alloHSCT. Scope of review In this paper, we review the glycosylation research already done in the field of alloHSCT and GVHD and evaluate further potential of glycan analysis in GVHD by looking into resembling inflammatory and autoimmune conditions. Major Conclusions Glycan research could bring significant improvement in alloHSCT procedure with reduction in following complications, such as GVHD. Identifying glycan patterns that induce self-tolerance and the ones that cause the auto- and allo-immune response could lead to innovative and tissue- specific immunomodulative therapy instead of the current immunosuppressive treatment, enabling preservation of the graft-versus-tumor effect. Moreover, improved glycan pattern analyses could offer a more complete assessment and greatly needed dynamic biomarkers for GVHD. General significance This review is written with a goal to encourage glycan research in the field of alloHSCT and GVHD as a perspective tool leading to improved engraftment, discovery of much needed biomarkers for GVHD, enabling an appropriate therapy and improved monitoring of therapeutic response.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb,
GENOS d.o.o.,
Sveučilište Libertas
Profili:
Radovan Vrhovac
(autor)
Maja Pučić Baković
(autor)
Marija Pezer
(autor)
Dražen Pulanić
(autor)
Lana Grković
(autor)
Steven Živko Pavletić
(autor)
Damir Nemet
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus